What does this research mean for the field?

Rosacea affects approximately 5.5% of the global population, predominantly occurring in individuals aged 30 to 50 across all racial groups, with a tendency for greater severity in men. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Assess the regional and global prevalence of rosacea while analyzing relationships between disease occurrence, climatic variables, Fitzpatrick skin types, sex, and age.

August 30, 2026Russian Journal of Clinical Dermatology and Venereology

Rosacea epidemiology: a meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

GMGulgena R. Mustafina RMRegina Mankovskaia EKE.S. Kamalov

Discussion

Member takes

Overview

Meta-analysis reveals an approximate 5.5% global prevalence of rosacea peaking at ages 30 to 50, highlighting substantial disease burden across diverse climatic and demographic populations.

Key Points

Assess the regional and global prevalence of rosacea while analyzing relationships between disease occurrence, climatic variables, Fitzpatrick skin types, sex, and age.
Evaluated institutional rosacea incidence data from 2019 to 2023 at the Republican Dermatovenereology Dispensary in Ufa.
Reviewed 50 scientific publications identified across seven literature databases (including PubMed, ScienceDirect, and Elibrary) spanning 1989 through 2024.
Identified an overall global rosacea prevalence of approximately 5.5%, with the vast majority of cases manifesting in individuals aged 30 to 50 years.
Demonstrated that clinical subtypes occur with near-equal distribution across sexes and racial groups, though males exhibit greater disease severity.

Cite This Study

Mustafina et al. (2026) studied this question.

synapsesocial.com/papers/6a93f0576c1a8fb52e79c6ca https://doi.org/10.17116/klinderma202625041540

View Full Paper

Ask AI

Bookmark

August 30, 2026Russian Journal of Clinical Dermatology and Venereology

Rosacea epidemiology: a meta-analysis

View Full Paper

Ask AI

Bookmark

Authors

GMGulgena R. Mustafina RMRegina Mankovskaia EKE.S. Kamalov

Discussion

Member takes

Overview

Meta-analysis reveals an approximate 5.5% global prevalence of rosacea peaking at ages 30 to 50, highlighting substantial disease burden across diverse climatic and demographic populations.

Key Points

Assess the regional and global prevalence of rosacea while analyzing relationships between disease occurrence, climatic variables, Fitzpatrick skin types, sex, and age.
Evaluated institutional rosacea incidence data from 2019 to 2023 at the Republican Dermatovenereology Dispensary in Ufa.
Reviewed 50 scientific publications identified across seven literature databases (including PubMed, ScienceDirect, and Elibrary) spanning 1989 through 2024.
Identified an overall global rosacea prevalence of approximately 5.5%, with the vast majority of cases manifesting in individuals aged 30 to 50 years.
Demonstrated that clinical subtypes occur with near-equal distribution across sexes and racial groups, though males exhibit greater disease severity.

Cite This Study

Mustafina et al. (2026) studied this question.

synapsesocial.com/papers/6a93f0576c1a8fb52e79c6ca https://doi.org/10.17116/klinderma202625041540

View Full Paper

Ask AI

Bookmark